Most medium-sized industrialized countries have capacity to manufacture something like the Oxford vaccine. We're seeing that with the technologically similar R

Most medium-sized industrialized countries have capacity to manufacture something like the Oxford vaccine. We're seeing that with the technologically similar Russian Sputnik vaccine which has been widely licensed. It's being manufactured in China, Russia, India, South Korea (two sites), Italy, Germany, Spain, Brazil, and probably some others I'm forgetting. And I would disagree. There are of course institutions capable of funding such projects and acquiring the resources. They're called governments. Between funding, compulsory licensing and nationalization powers, if a nation has the theoretical ability to manufacture the vaccine, then that theoretical can become reality with the right policies. Canada did nothing until August 31st, around the time the federal government realized we were not going to be able to acquire doses from the USA/EU with priority. Then two plants got emergency funding. They will come online this fall and will likely produce 50+ million doses this year, some of the Novavax vaccine, some of another promising candidate vaccine developed domestically. Both have been ready to test since March 2020. If they had been funded then, we may already have had domestically manufactured doses available.